1594129-72-2

Upstream product

• 27298-97-1 (S)-1-(4-bromophenyl)ethylamine 
• 186296-23-1 (S)-N-(1-(4-bromophenyl)ethyl)acetamide 
• 1594129-68-6 N-((S)-1-(4-((R)-pyrrolidin-3-yloxy)phenyl)ethyl)acetamide hydrochloride 
• 1594129-62-0 (R)-tert-butyl 3-(4-((S)-1-acetamidoethyl)phenoxy)pyrrolidine-1-carboxylate 
• 1443670-29-8 (S)-N-(1-(4-hydroxyphenyl)ethyl)acetamide 

Downstream Products

• 1594127-56-6 C₂₂H₂₈N₂O₃ 
• 1594127-55-5 N-((S)-1-(4-((R)-1-(4-(cyclopropylmethoxy)phenyl)pyrrolidin-3-ylox)phenyl)ethyl)-acetamide 
• 1594127-63-5 C₂₄H₃₂N₂O₄ 
• 1620685-16-6 C₂₃H₂₈FN₃O₃ 
• 1620685-12-2 C₂₂H₂₉N₃O₃ 
• 1620686-02-3 C₂₂H₂₉N₃O₄ 
• 1620685-11-1 C₂₂H₂₉N₃O₃ 
• 1620688-87-0 N-((S)-1-(4-((R)-1-(6-(trifluoromethyl)pyridin-2-yl)pyrrolidin-3-yloxy)phenyl)ethyl)acetamide 

Relevant academic research and scientific papers

NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

The invention relates to new pyrrolidine derivatives of the formula (I) to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new pyrrolidine derivatives of the formula (I), to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new pyrrolidine derivatives of the formula wherein R1 to R3, Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical

New pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Pyrrolidine derivatives of the formula and their use as medicaments for the treatment of obesity and type 2 diabetes.

PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

The invention relates to new pyrrolidine derivatives of the formula (I), wherein R1 to R3, Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceu